期刊文献+

实时荧光PCR用于CYP2C19基因多态性检测的性能验证 被引量:4

Performance of real-time fluorescence PCR for the determination of CYP2C19 polymorphisms
暂未订购
导出
摘要 目的评价实时荧光聚合酶链反应(PCR)检测细胞色素P450家族成员2C19(CYP2C19)基因多态性的精密度、准确度和检测限。方法采用实时荧光PCR对基因型为*1/*1、*1/*2、*1/*3和*1/*17的DNA样本分别作批内重复扩增10次,以评价方法的精密度;比较实时荧光PCR与Sanger测序法的检测结果,以评价方法的准确性;对2倍梯度稀释的DNA样本(基因型为*1/*1、*1/*2、*1/*3和*1/*17)进行实时荧光PCR扩增,以评价方法的最低检测限。结果批内重复10次的分型检测结果完全一致,所有PCR的Ct值变异系数(CV)均<2.5%;实时荧光PCR的分型结果与Sanger测序法结果的符合率为100%(20/20),其中*1/*17型1例、*1/*1型3例、*1/*2型5例、*1/*3型5例、*2/*2型4例、*2/*3型2例;实时荧光PCR的最低检测限为1.875 ng/μL DNA。结论实时荧光PCR的基因分型结果稳定、可靠,适用于医学实验室CYP2C19基因多态性的检测。 Objective To evaluate the precision,accuracy and limit of detection of real-time fluorescencepolymerase chain reaction(PCR)for cytochrome P4502C19(CYP2C19)polymorphisms.Methods DNAsamples with different CYP2C19genotypes(*1/*1,*1/*2,*1/*3and*1/*17)were determined for10times in1run for evaluating precision.The results of real-time fluorescence PCR and Sanger sequencing were used and comparedfor evaluating accuracy.The DNA samples with different genotypes(*1/*1,*1/*2,*1/*3and*1/*17)were dilutedin a2-fold serial pattern and determined by real-time fluorescence PCR for evaluating limit of detection.Results Real-time fluorescence PCR showed low coefficient of variation(CV)of Ct values(<2.5%),a low limit ofdetection of1.875ng/μL and accuracy of100%(20/20)compared to the results of Sanger sequencing,including6kinds of CYP2C19genotypes in20cases(1case of*1/*17,3cases of*1/*1,5cases of*1/*2,5cases of*1/*3,4cases of*2/*2and2cases of*2/*3).Conclusions Real-time fluorescence PCR is precise,accurate and suitablefor CYP2C19polymorphisms.
作者 陈丹 徐婷 张洁心 赵鸿 戎国栋 潘世扬 王芳 黄珮珺 CHEN Dan;XU Ting;ZHANG Jiexin;ZHAO Hong;RONG Guodong;PAN Shiyang;WANG Fang;HUANG Peijun(Department of Clinical Laboratory,the First Affiliated Hospital of Nanjing Medical University/the National Key Clinical Department of Laboratory Medicine,Nanjing 210029,Jiangsu,China)
出处 《检验医学》 CAS 2017年第9期801-805,共5页 Laboratory Medicine
基金 江苏省实验诊断学重点实验室基金项目(XK201114)
关键词 细胞色素P450家族成员2C19 基因多态性 药物代谢酶 实时荧光聚合酶链反应 性能验证 Cytochrome P450 2C19 Gene polymorphism Drug-metabolizing enzyme Real-time fluorescence polymerase chain reaction Proficiency testing
  • 相关文献

参考文献3

二级参考文献71

  • 1中国合格评定国家认可委员会.CNAS-GL03能力验证样品均匀性和稳定性评价指南[S].,2006..
  • 2Alomar MJ. Factors affecting the development of adverse drug re- actions (Review article)[J]. Saudi Pharm J, 2014, 22(2): 83- 94.
  • 3Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventa- bility of adverse drug events among older persons in the ambulatory setting[J]. JAMA, 2003, 289(9): 1107-1116.
  • 4Pirmohamed M, Park BK. Genetic susceptibility to adverse drug reactions[J]. Trends Pharmacol Sci, 2001, 22(6) : 298-305.
  • 5Meyer UA, Phm~acogenetics and adverse drug reactions [ J ]. Lancet, 2000, 356(9242) : 1667-1671.
  • 6Edwards IR, Aronson JK. Adverse drag reactions : definitions, di- agnosis, and management [J]. Lancet, 2000, 356 (9237) : 1255- 1259.
  • 7Depondt C, Godard P, Espel RS, et al. A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxieity[J]. Eur J Neurol, 2011, 18(9): 1159-1164.
  • 8Gupta VH, Amarapurkar DN, Singh M, et al. Association of N- aeetyltransferase 2 and cytoehrome P450 2El gene polymorphisms with antitubereulosis drug-induced hepatotoxicity in Western India [J]. J Gastroenterol Hepatol, 2013, 28(8) : 1368-1374.
  • 9Liu SG, Li ZG, Cui L, et al. Effects of methylenetetrahydroiblate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population [ J ]. Leuk Lymphoma, 2011, 52 (6) : 1030-1040.
  • 10Erbek SS, Yurtcu E, Erbek S, et al. Matrix metalloproteinase-9 promoter gene polymorphism (-1562C > T) in nasal polyposis[ J]. Am J Rhinol Allergy, 2009, 23(6) : 568-570.

共引文献9

同被引文献19

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部